Pexelizumab: ALXN and partner Procter & Gamble (PG, Cincinnati, Ohio) began the placebo-controlled PRIMO-CABG Phase III trial of pexelizumab in 3,000 patients u

Alexion Pharmaceuticals Inc. (ALXN), New Haven, Conn. Product: Pexelizumab (5G1.1-SC) Business: Cardiovascular Therapeutic category: Membrane attack Target: C5 complement Description: Antibody fragme...